DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADB113186
Title:
Preformulation and Formulation of Investigational New Drugs
Corporate Author:
IOWA UNIV IOWA CITY COLL OF PHARMACY
Report Date:
1985-07-01
Abstract:
This annual report contains preformulation and formulation studies on WR249,655.2CHI-6.2C1, WR238,605, WR171,669.HC1 Halofantrine HC1, WR249,943. 2C1 MMB-4.2CL, WR142,490.HC1 MEFLOQUINE CH1 and Pyridostigmine Bromide. These studies include stability studies on WR249,655.2CL and WR249,943.2C1 physicochemical characterization of WR238,605 investigation of solid-state properties of various lots of WR171,669.HCL and WR142,490.HCL initial development studies for a sustained release pyridostigmine bromide tablet. Keywords Oximes Antioxidents Antidotes.
Descriptive Note:
Annual progress rept. 10 Mar 1984-10 Feb 1985
Supplementary Note:
DOI: 10.21236/ADB113186
Pages:
0163
Contract Number:
DAMD17-85-C-5003
File Size:
4.89MB
